Amgen to Present at Bank of America Merrill Lynch Healthcare Conference
TL/DR –
Amgen will present at the Bank of America Merrill Lynch Global Healthcare Conference on May 14, 2025. The presentation by executives Peter Griffith and Jay Bradner will be broadcast over the internet for news media, investors, and the public. Amgen, which was named one of the “World’s Most Innovative Companies” by Fast Company in 2024, focuses on the discovery, development, and delivery of innovative medicines for various diseases.
Amgen to Present at Bank of America Merrill Lynch Global Healthcare Conference
Amgen (NASDAQ:AMGN), renowned biotech company, is slated to present at the Bank of America Merrill Lynch Global Healthcare Conference. The presentation is scheduled for 9:20 a.m. PT on Wednesday, May 14, 2025. Peter Griffith, executive vice president and CFO, and Jay Bradner, EVP of Research and Development and chief scientific officer, will be the presenters. The event will be webcast live for news media, investors, and the public.
Webcast Details
The webcast, along with other presentational content from Amgen management, is accessible via the Amgen website. Details about the presentation, webcast availability times, and links can be found under the Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen is committed to discovering, developing, manufacturing, and delivering innovative medicines for patients grappling with difficult diseases. With over 40 years of experience, Amgen’s advancements in biotechnology have made it an industry pioneer. The company is known for its broad pipeline of medicines treating conditions like cancer, heart disease, osteoporosis, inflammatory diseases, and rare diseases.
In 2024, Amgen earned the title of one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes, along with other recognitions. It is one of the 30 companies in the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®.
For more details, visit Amgen.com and follow them on Twitter, LinkedIn, Instagram, YouTube, and Threads.
Contact Information
For media inquiries, contact Elissa Snook at 609-251-1407. For investors, reach out to Justin Claeys at 805-313-9775.
View original content and download multimedia.
—
Read More Health & Wellness News ; US News